FIRSTS IN PATIENT CARE
In February 2026 physicians at Riley Children’s Health performed the world’s first successful pediatric bone marrow stem cell transplant using cells from a deceased donor. Fourteen-year-old Noah Britt received a deceased donor bone marrow stem cell transplant through the HOPE Program, an expanded-access arm of the PRESERVE I clinical trial. The program provides cryopreserved hematopoietic progenitor cell (HPC) marrow to patients ages 12 to 80 who urgently need a transplant but are unable to find a suitable living donor match. READ about this revolutionary procedure offering potential new treatment options for pediatric cancer patients. FORERUNNERS > “When Noah’s first transplant failed and he had no available living donor matches, we were facing a race against time. Because these stem cells are banked and ready to use, we were able to act in days instead of months. This treatment has the potential to dramatically expand access to transplant for children who previously had few or no remaining treatment options, giving us a way to close critical gaps in care and offer hope to families facing impossible circumstances.”
Jodi L. Skiles, MD Medical Director, Pediatric Stem Cell Transplant and Cellular Therapy, Riley Children’s Health Associate Professor of Clinical Pediatrics, IU School of Medicine > Connect with Dr. Skiles on Doximity.
With access to the latest clinical trials and therapies, Riley specialists treat the full spectrum of pediatric cancers and blood diseases, including aggressive conditions that are no longer responsive to conventional therapy. > Learn more about our program.
HEMATOLOGY, ONCOLOGY & STEM CELL TRANSPLANT AT RILEY CHILDREN’S
Made with FlippingBook flipbook maker